Literature DB >> 26262130

Identifying Diseases, Drugs, and Symptoms in Twitter.

Antonio Jimeno-Yepes1, Andrew MacKinlay1, Bo Han1, Qiang Chen1.   

Abstract

Social media sites, such as Twitter, are a rich source of many kinds of information, including health-related information. Accurate detection of entities such as diseases, drugs, and symptoms could be used for biosurveillance (e.g. monitoring of flu) and identification of adverse drug events. However, a critical assessment of performance of current text mining technology on Twitter has not been done yet in the medical domain. Here, we study the development of a Twitter data set annotated with relevant medical entities which we have publicly released. The manual annotation results show that it is possible to perform high-quality annotation despite of the complexity of medical terminology and the lack of context in a tweet. Furthermore, we have evaluated the capability of state-of-the-art approaches to reproduce the annotations in the data set. The best methods achieve F-scores of 55-66%. The data analysis and the preliminary results provide valuable insights on identifying medical entities in Twitter for various applications.

Mesh:

Substances:

Year:  2015        PMID: 26262130

Source DB:  PubMed          Journal:  Stud Health Technol Inform        ISSN: 0926-9630


  13 in total

1.  A systematic literature review of machine learning in online personal health data.

Authors:  Zhijun Yin; Lina M Sulieman; Bradley A Malin
Journal:  J Am Med Inform Assoc       Date:  2019-06-01       Impact factor: 4.497

2.  Detection of Adverse Drug Reactions using Medical Named Entities on Twitter.

Authors:  Andrew MacKinlay; Hafsah Aamer; Antonio Jimeno Yepes
Journal:  AMIA Annu Symp Proc       Date:  2018-04-16

3.  Ontology-Based Healthcare Named Entity Recognition from Twitter Messages Using a Recurrent Neural Network Approach.

Authors:  Erdenebileg Batbaatar; Keun Ho Ryu
Journal:  Int J Environ Res Public Health       Date:  2019-09-27       Impact factor: 3.390

4.  A systematic review of natural language processing and text mining of symptoms from electronic patient-authored text data.

Authors:  Caitlin Dreisbach; Theresa A Koleck; Philip E Bourne; Suzanne Bakken
Journal:  Int J Med Inform       Date:  2019-02-20       Impact factor: 4.046

5.  Finding the Patient's Voice Using Big Data: Analysis of Users' Health-Related Concerns in the ChaCha Question-and-Answer Service (2009-2012).

Authors:  Chad Priest; Amelia Knopf; Doyle Groves; Janet S Carpenter; Christopher Furrey; Anand Krishnan; Wendy R Miller; Julie L Otte; Mathew Palakal; Sarah Wiehe; Jeffrey Wilson
Journal:  J Med Internet Res       Date:  2016-03-09       Impact factor: 5.428

6.  Combining Social Media and FDA Adverse Event Reporting System to Detect Adverse Drug Reactions.

Authors:  Ying Li; Antonio Jimeno Yepes; Cao Xiao
Journal:  Drug Saf       Date:  2020-09       Impact factor: 5.606

7.  Deep neural networks ensemble for detecting medication mentions in tweets.

Authors:  Davy Weissenbacher; Abeed Sarker; Ari Klein; Karen O'Connor; Arjun Magge; Graciela Gonzalez-Hernandez
Journal:  J Am Med Inform Assoc       Date:  2019-12-01       Impact factor: 4.497

8.  Prospective Evaluation of Adverse Event Recognition Systems in Twitter: Results from the Web-RADR Project.

Authors:  Lucie M Gattepaille; Sara Hedfors Vidlin; Tomas Bergvall; Carrie E Pierce; Johan Ellenius
Journal:  Drug Saf       Date:  2020-08       Impact factor: 5.606

9.  Design Choices for Automated Disease Surveillance in the Social Web.

Authors:  Mark Abraham Magumba; Peter Nabende; Ernest Mwebaze
Journal:  Online J Public Health Inform       Date:  2018-09-21

Review 10.  Utility of social media and crowd-intelligence data for pharmacovigilance: a scoping review.

Authors:  Andrea C Tricco; Wasifa Zarin; Erin Lillie; Serena Jeblee; Rachel Warren; Paul A Khan; Reid Robson; Ba' Pham; Graeme Hirst; Sharon E Straus
Journal:  BMC Med Inform Decis Mak       Date:  2018-06-14       Impact factor: 2.796

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.